| abstract |
The present invention provides novel compounds that enhance the entry of L-arginine into cells. These compounds have the potential to slow the progression of vascular disease in conditions such as hypertension, heart failure and diabetes by improving endothelial function. This new class of drugs may also have other potentially related pharmacological effects such as antihypertensive and antianginal effects. |